Aspergillus fumigatus extract modulates human eosinophils via NOD2 and oxidative stress

Autor: Sasaki, Hisashi ^a, Miyata, Jun ^{a, b, ⁎}, Kawashima, Yusuke ^c, Konno, Ryo ^c, Ishikawa, Masaki ^c, Hasegawa, Yoshinori ^c, Onozato, Ryuta ^b, Otsu, Yo ^b, Matsuyama, Emiko ^b, Sunata, Keeya ^b, Masaki, Katsunori ^b, Kabata, Hiroki ^b, Kimizuka, Yoshifumi ^a, Abe, Tomoe ^d, Ueki, Shigeharu ^d, Asano, Koichiro ^e, Kawana, Akihiko ^a, Fukunaga, Koichi ^b

Publikováno v: In Allergology International January 2025 74(1):156-165

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TRPV1 Channel in Human Eosinophils: Functional Expression and Inflammatory Modulation.

Autor: Weihrauch, Tobias¹ (AUTHOR), Gray, Natalie^1,2 (AUTHOR), Wiebe, Daniela¹ (AUTHOR), Schmelz, Martin³ (AUTHOR), Limberg, Maren M.¹ (AUTHOR), Raap, Ulrike^1,4,5 (AUTHOR) raap.ulrike@klinikum-oldenburg.de

Publikováno v: International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1922. 15p.

Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma.

Autor: Esnault S; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Bernau K; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Floerke HL; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Dendooven A; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Delaunay E; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Dill-McFarland KA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA., Altman MC; Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.; Systems Immunology Division, Benaroya Research Institute, Seattle, Washington, USA., Busse WW; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Rosenkranz MA; Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, USA.; Department of Psychiatry, University of Wisconsin-Madison, Madison, Wisconsin, USA., Tattersall MC; Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Johansson MW; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Labreuche J; Health Statistics, SEED: Statistique, évaluation, économique, Data-Management Maison Régionale de la Recherche Clinique University Hospital of Lille, Lille, France., Beury D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, US 41-UAR 2014-PLBS, Lille, France., Sebda S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, US 41-UAR 2014-PLBS, Lille, France., Dezoteux F; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Département de Dermatologie, CHU Lille, Lille, France.; CEREO, National Reference Center for Hypereosinophilic Syndromes, Suresnes, France., Segard B; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Département d'oto-Rhino-Laryngologie, CHU Lille, Lille, France., Mortuaire G; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; CEREO, National Reference Center for Hypereosinophilic Syndromes, Suresnes, France.; Département d'oto-Rhino-Laryngologie, CHU Lille, Lille, France., Staumont-Sallé D; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Département de Dermatologie, CHU Lille, Lille, France.; CEREO, National Reference Center for Hypereosinophilic Syndromes, Suresnes, France., Stoup T; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Chenivesse C; CEREO, National Reference Center for Hypereosinophilic Syndromes, Suresnes, France.; Univ. Lille, CHU Lille, CNRS, Inserm, Institut Pasteur Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, Lille, France.; CRISALIS (Clinical Research Initiative in Severe Asthma: A Lever for Innovation & Science), Toulouse, France., Sandbo N; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Jarjour NN; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Lefèvre G; Univ. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; CEREO, National Reference Center for Hypereosinophilic Syndromes, Suresnes, France.; CHU Lille, Institut d'Immunologie, Médecine Interne et Immunologie Clinique, Lille, France.

Publikováno v: Allergy [Allergy] 2024 Dec 21. Date of Electronic Publication: 2024 Dec 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.